• Nachrichtendetail
• 

27.03.2024 07:00:14 - *DJ Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China's NMPA

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	Santhera Pharmaceuticals NA	A0LCUK	Schweiz	9,520	28.05.24 22:05:00	+0,230	+2,48%	9,400	9,550	9,300	9,520